Project Grant R35GM158136
- The federal Project Grant award of $453,750.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to President and Fellows of Harvard College (doing business as Harvard Medical School) on April 16, 2025. The grant supports the development of advanced mass spectrometry-based proteomics workflows to improve throughput, depth, and accuracy in profiling protein abundance, post-translational...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $254,233 to the President and Fellows of Harvard College, doing business as Harvard Medical School, to conduct research on the "Regulation of Steroid Hormone Signaling and Lipid Metabolism by the Tuberous Sclerosis Complex." The award period runs from April 1, 2025 to March 31, 2027. As a leading academic research institution, Harvard...
- This Project Grant award of $540,000 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to expand the MicroTutor online platform for microscopy and bioimage analysis education. The primary awardee, President and Fellows of Harvard College, doing business as Harvard Medical School, will add new modules on microscopy best practices and bioimage analysis using open-source tools like Piximi. This will...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), is focused on elucidating the role of selective Golgi remodeling in cellular homeostasis. The $125,000 award, with a project period from July 17, 2025 to June 30, 2027, will support research conducted by the President and Fellows of Harvard College, doing business as Harvard Medical School. The research aims to understand the...
- The National Institute of General Medical Sciences (NIGMS) awarded a $1,451,970 project grant under CFDA 93.859 (Biomedical Research and Research Training) to President and Fellows of Harvard College, doing business as Harvard Medical School, for a research project titled "Evolutionary Tradeoffs in Antibiotic Resistance." The grant period runs from February 1, 2025 to December 31, 2029. The research project aims to study evolutionary factors that influence the development of antibiotic...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a $1,516,500 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to Harvard University's Office for Sponsored Programs Division. The grant, effective from September 1, 2025 to August 31, 2028, supports research to develop organic, metal-free catalysts capable of performing chemical processes traditionally enabled by transition metals. The goal is to discover strategies that use entire...
- This federal Project Grant award of $617,007 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to conduct research on the molecular mechanisms of DNA double-strand break repair through non-homologous end joining (NHEJ). The research aims to elucidate how DNA ends are held together and coordinated with end processing enzymes to maximize the fidelity of NHEJ and minimize genome alterations. The...
- This federal Project Grant award of $321,270 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the Harvard Biophysics Graduate Program Training Grant. The grant aims to provide students with a broad, interdisciplinary training in biophysics, chemistry, and molecular biology to address important questions at the interface of the physical and biological sciences. The program offers a flexible...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $637,729 to President and Fellows of Harvard College (doing business as Harvard Medical School) from December 13, 2024 to November 30, 2029. The funding supports research to investigate the molecular mechanisms underlying the activation and regulation of essential bacterial cell wall synthase enzymes, with...
- This Project Grant award from the National Institutes of Health's National Institute of General Medical Sciences provides $227,480.44 to President and Fellows of Harvard College, doing business as Harvard Medical School, to conduct research from May 1, 2021 through September 30, 2022. The research will comprehensively examine condition-specific mRNA isoforms and their properties, as well as cellular factors involved in regulating isoform half-lives on a genome-wide scale under various...
This $2,527,500.00 Project Grant was awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to President and Fellows of Harvard College, doing business as Harvard Medical School, with a performance period from September 1, 2025 to August 31, 2029. The grant supports a research project focused on advancing sample multiplexing technology as a key enabling tool for quantitative proteomics, which aims to improve the understanding of protein function and accelerate progress in medical research. The project leverages Harvard Medical School's expertise in mass spectrometry-based proteomics and prior contributions to sample multiplexing techniques. The research is expected to address important priorities in the field of proteomics by enhancing throughput and enabling the discovery of selective pharmacological tools to perturb and reveal protein function.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 8/25/25 |